 |
PDBsum entry 2hdp
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.3.2.27
- RING-type E3 ubiquitin transferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
363:433-450
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53.
|
|
M.Kostic,
T.Matt,
M.A.Martinez-Yamout,
H.J.Dyson,
P.E.Wright.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Regulation of the transcriptional response to the tumor suppressor p53 occurs at
many levels, including control of its transcriptional activity, and of its
stability and concentration within the cell. p53 stability is regulated by the
protein Hdm2, an E3 ubiquitin ligase that binds to p53 and promotes its
ubiquitination and degradation. The C-terminal domain of Hdm2, which is critical
for this activity, has been classified as a RING domain on the basis of sequence
homology, although it lacks the canonical set of zinc ligands (RING domains
typically have C3HC4 or C4C4 zinc coordination). Here, we report the solution
structure of the C2H2C4 RING domain of Hdm2(429-491), which reveals a
symmetrical dimer with a unique cross-brace zinc-binding scheme. Each subunit
has one Cys4 Zn site and one His2Cys2 Zn site. The global fold of each subunit
is similar to those reported for other RING domains, with a compact
betabetaalphabeta fold, a small hydrophobic core, and two Zn ions, which are
essential for maintaining the domain structure. The dimer structure is
maintained by an extensive interface that buries a large hydrophobic area on
each subunit. It has been proposed that Hdm2 and its homologue HdmX form a
stable heterodimer through their RING domains, resulting in a synergistic
increase in observed E3 activity. To test this proposal, we prepared an HdmX
RING construct and showed by NMR titration that it forms a tight 1:1 complex
with the Hdm2 RING. The resonances most perturbed by heterodimer formation are
located within the subunit interface of the homodimer, far removed from the
surface expected to form the docking site of the E2 ubiquitin-conjugating
enzyme, providing a structure-based rationale for the function of the RING
domains in p53 ubiquitination.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 6.
Figure 6. Solution structure of Hdm2(429–491) C2H2C4 RING
domain. (a) Superposition of an ensemble of 20 lowest energy
structures of the Hdm2(429–491) C2H2C4 RING homodimer, with
the two subunits colored green and gold. The first eight and the
last residue are not well-defined and are omitted for clarity.
Zinc ions are shown as gray spheres. The Figure was prepared
using PyMOL [http://www.pymol.sourceforge.net/]. (b) A ribbon
representation of the lowest energy structure of a single
subunit of Hdm2(429–491), showing the distribution of regular
secondary structure elements and the location of two
Zn^2+-binding sites. The side-chains of the zinc ligands are
shown as balls, colored black (C), blue (N) or yellow (S). This
Figure was prepared using MOLMOL.^78
|
 |
Figure 10.
Figure 10. Structural overlay of the UbcH7/c-Cbl complex
(PDB 1FBV)^55 with the UbcH5b structure (PDB 2ESK)^65 and the
lowest-energy structure of the Hdm2(429–491) homodimer. This
Figure was prepared using MOLMOL.^78
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2006,
363,
433-450)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Priest,
C.Prives,
and
M.V.Poyurovsky
(2010).
Deconstructing nucleotide binding activity of the Mdm2 RING domain.
|
| |
Nucleic Acids Res,
38,
7587-7598.
|
 |
|
|
|
|
 |
C.T.Chasapis,
A.K.Loutsidou,
M.G.Orkoula,
and
G.A.Spyroulias
(2010).
Zinc Binding Properties of Engineered RING Finger Domain of Arkadia E3 Ubiquitin Ligase.
|
| |
Bioinorg Chem Appl,
(),
0.
|
 |
|
|
|
|
 |
J.C.Marine,
and
G.Lozano
(2010).
Mdm2-mediated ubiquitylation: p53 and beyond.
|
| |
Cell Death Differ,
17,
93.
|
 |
|
|
|
|
 |
M.Wade,
Y.V.Wang,
and
G.M.Wahl
(2010).
The p53 orchestra: Mdm2 and Mdmx set the tone.
|
| |
Trends Cell Biol,
20,
299-309.
|
 |
|
|
|
|
 |
P.D.Mace,
S.Shirley,
and
C.L.Day
(2010).
Assembling the building blocks: structure and function of inhibitor of apoptosis proteins.
|
| |
Cell Death Differ,
17,
46-53.
|
 |
|
|
|
|
 |
A.J.Levine,
and
M.Oren
(2009).
The first 30 years of p53: growing ever more complex.
|
| |
Nat Rev Cancer,
9,
749-758.
|
 |
|
|
|
|
 |
B.Wawrzynow,
S.Pettersson,
A.Zylicz,
J.Bramham,
E.Worrall,
T.R.Hupp,
and
K.L.Ball
(2009).
A function for the RING finger domain in the allosteric control of MDM2 conformation and activity.
|
| |
J Biol Chem,
284,
11517-11530.
|
 |
|
|
|
|
 |
C.A.Corcoran,
J.Montalbano,
H.Sun,
Q.He,
Y.Huang,
and
M.S.Sheikh
(2009).
Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.
|
| |
J Biol Chem,
284,
21955-21970.
|
 |
|
|
|
|
 |
E.G.Worrall,
B.Wawrzynow,
L.Worrall,
M.Walkinshaw,
K.L.Ball,
and
T.R.Hupp
(2009).
Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif.
|
| |
J Chem Biol,
2,
113-129.
|
 |
|
|
|
|
 |
F.Mancini,
G.D.Conza,
and
F.Moretti
(2009).
MDM4 (MDMX) and its Transcript Variants.
|
| |
Curr Genomics,
10,
42-50.
|
 |
|
|
|
|
 |
M.Wade,
and
G.M.Wahl
(2009).
Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?
|
| |
Mol Cancer Res,
7,
1.
|
 |
|
|
|
|
 |
Q.Yin,
S.C.Lin,
B.Lamothe,
M.Lu,
Y.C.Lo,
G.Hura,
L.Zheng,
R.L.Rich,
A.D.Campos,
D.G.Myszka,
M.J.Lenardo,
B.G.Darnay,
and
H.Wu
(2009).
E2 interaction and dimerization in the crystal structure of TRAF6.
|
| |
Nat Struct Mol Biol,
16,
658-666.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.A.Barboza,
T.Iwakuma,
T.Terzian,
A.K.El-Naggar,
and
G.Lozano
(2008).
Mdm2 and Mdm4 loss regulates distinct p53 activities.
|
| |
Mol Cancer Res,
6,
947-954.
|
 |
|
|
|
|
 |
J.A.Lehman,
J.A.Eitel,
C.N.Batuello,
and
L.D.Mayo
(2008).
Therapeutic considerations for Mdm2: not just a one trick pony.
|
| |
Expert Opin Drug Discov,
3,
1309-1321.
|
 |
|
|
|
|
 |
K.Linke,
P.D.Mace,
C.A.Smith,
D.L.Vaux,
J.Silke,
and
C.L.Day
(2008).
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.
|
| |
Cell Death Differ,
15,
841-848.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.G.Sivakolundu,
A.Nourse,
S.Moshiach,
B.Bothner,
C.Ashley,
J.Satumba,
J.Lahti,
and
R.W.Kriwacki
(2008).
Intrinsically unstructured domains of Arf and Hdm2 form bimolecular oligomeric structures in vitro and in vivo.
|
| |
J Mol Biol,
384,
240-254.
|
 |
|
|
|
|
 |
C.Boularan,
M.G.Scott,
K.Bourougaa,
M.Bellal,
E.Esteve,
A.Thuret,
A.Benmerah,
M.Tramier,
M.Coppey-Moisan,
C.Labbé-Jullié,
R.Fåhraeus,
and
S.Marullo
(2007).
beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.
|
| |
Proc Natl Acad Sci U S A,
104,
18061-18066.
|
 |
|
|
|
|
 |
K.Itahana,
H.Mao,
A.Jin,
Y.Itahana,
H.V.Clegg,
M.S.Lindström,
K.P.Bhat,
V.L.Godfrey,
G.I.Evan,
and
Y.Zhang
(2007).
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.
|
| |
Cancer Cell,
12,
355-366.
|
 |
|
|
|
|
 |
M.V.Poyurovsky,
C.Priest,
A.Kentsis,
K.L.Borden,
Z.Q.Pan,
N.Pavletich,
and
C.Prives
(2007).
The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity.
|
| |
EMBO J,
26,
90.
|
 |
|
|
|
|
 |
P.Knipscheer,
and
T.K.Sixma
(2007).
Protein-protein interactions regulate Ubl conjugation.
|
| |
Curr Opin Struct Biol,
17,
665-673.
|
 |
|
|
|
|
 |
R.K.Singh,
S.Iyappan,
and
M.Scheffner
(2007).
Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.
|
| |
J Biol Chem,
282,
10901-10907.
|
 |
|
|
|
|
 |
S.Uldrijan,
W.J.Pannekoek,
and
K.H.Vousden
(2007).
An essential function of the extreme C-terminus of MDM2 can be provided by MDMX.
|
| |
EMBO J,
26,
102-112.
|
 |
|
|
|
|
 |
X.Tang,
S.Orlicky,
Z.Lin,
A.Willems,
D.Neculai,
D.Ceccarelli,
F.Mercurio,
B.H.Shilton,
F.Sicheri,
and
M.Tyers
(2007).
Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination.
|
| |
Cell,
129,
1165-1176.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |